Cargando…

Immunosuppressant Agents in the Treatment of Glomerulonephritis: Part 1. Corticosteroid Drugs

Detalles Bibliográficos
Autor principal:	Cameron, J. S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Royal College of Physicians of London 1971
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5366629/ https://www.ncbi.nlm.nih.gov/pubmed/4361123

Ejemplares similares

Immunosuppressant Agents in the Treatment of Glomerulonephritis: Part 2. Cytotoxic Drugs
por: Cameron, J. S.
Publicado: (1971)

Antineoplastic and Immunosuppressive Agents—Part 1
por: Lajtha, L. G.
Publicado: (1975)

Pharmacokinetic Drug–Drug Interactions Between Immunosuppressant and Anti-Infective Agents: Antimetabolites and Corticosteroids
por: Van Matre, Edwart T., et al.
Publicado: (2018)

Counselling for Kidney Biopsy and Immunosuppression in Glomerulonephritis Using Simulation
por: Lim, Cynthia Ciwei, et al.
Publicado: (2022)

Use of Immunosuppressive Therapy in the Treatment of IgA-dominant Infection-related Glomerulonephritis
por: Okumura, Motohiro, et al.
Publicado: (2022)

Post-infectious glomerulonephritis following infective endocarditis: Amenable to immunosuppression
por: Mantan, M., et al.
Publicado: (2013)

Towards treatment planning of COVID-19: Rationale and hypothesis for the use of multiple immunosuppressive agents: Anti-antibodies, immunoglobulins, and corticosteroids
por: Saghazadeh, Amene, et al.
Publicado: (2020)

The BC Glomerulonephritis Network: Improving Access and Reducing the Cost of Immunosuppressive Treatments for Glomerular Diseases
por: Barbour, Sean, et al.
Publicado: (2018)

Efficacy of Corticosteroids in Infection-Related Glomerulonephritis–A Randomized Controlled Trial
por: Arivazhagan, Srinivasan, et al.
Publicado: (2022)

S-Fas Urinary Excretion Helps to Predict the Immunosuppressive Treatment Outcomes in Patients with Proliferative Primary Glomerulonephritis
por: Zwiech, Rafał
Publicado: (2013)

Synergistic impact of pre-diabetes and immunosuppressants on the risk of diabetes mellitus during treatment of glomerulonephritis and renal vasculitis
por: Lim, Cynthia Ciwei, et al.
Publicado: (2020)

Long‐Term Corticosteroid‐Sparing Immunosuppression for Cardiac Sarcoidosis
por: Rosenthal, David G., et al.
Publicado: (2019)

Corticosteroids/immunosuppressants: Coronavirus disease 2019: case report
Publicado: (2020)

Pharmacological immunosuppressive agents.
por: Salaman, J. R.
Publicado: (1981)

Good efficacy achieved by telitacicept, corticosteroids and immunosuppressants in the treatment of SLE combined with MOG-AD
por: Tian, Mengxue, et al.
Publicado: (2023)

Corticosteroid and Immunosuppressant Therapy for Cardiac Sarcoidosis: A Systematic Review
por: Fazelpour, Siavosh, et al.
Publicado: (2021)

Cardiac sarcoidosis: systematic review of the literature on corticosteroid and immunosuppressive therapies
por: Stievenart, Julien, et al.
Publicado: (2022)

Comparative effectiveness of immunosuppressive drugs and corticosteroids for lupus nephritis: a systematic review and network meta-analysis
por: Singh, Jasvinder A., et al.
Publicado: (2016)

Treatment of Primary Glomerulonephritis
por: Oliveira, David B G
Publicado: (1997)

Fibrillary glomerulonephritis presenting as crescentic glomerulonephritis
por: Shah, H. H., et al.
Publicado: (2017)

Long-Term Results of Triple Immunosuppression With Tacrolimus Added to Mycophenolate and Corticosteroids in the Treatment of Lupus Nephritis
por: Yap, Desmond Y.H., et al.
Publicado: (2021)

Sequential Treatment by Antiviral Drugs Followed by Immunosuppressive Agents for COVID-19 Patients with Hematological Malignancy
por: Seki, Masafumi, et al.
Publicado: (2022)

Omalizumab as a corticosteroid‐sparing agent in the treatment of bullous pemphigoid
por: Vassallo, Camilla, et al.
Publicado: (2022)

Fibrillary glomerulonephritis with small fibrils in a patient with the antiphospholipid antibody syndrome successfully treated with immunosuppressive therapy
por: Javaid, Muhammad M, et al.
Publicado: (2007)

Infection-related hospitalization after intensive immunosuppressive therapy among lupus nephritis and ANCA glomerulonephritis patients
por: Yin, Peihong, et al.
Publicado: (2020)

Cardiovascular effects of immunosuppression agents
por: Elezaby, Aly, et al.
Publicado: (2022)

Immunosuppressive Drugs
por: Hussain, Yaseen, et al.
Publicado: (2022)

Drug Interactions between Antimicrobial and Immunosuppressive Agents in Solid Organ Transplant Recipients
por: Bhagat, Vikas, et al.
Publicado: (2021)

Acute tubular necrosis as a part of vancomycin induced drug rash with eosinophilia and systemic symptoms syndrome with coincident postinfectious glomerulonephritis
por: Kim, Kyung Min, et al.
Publicado: (2016)

Unusual clinical presentation of cutaneous leishmaniasis in a patient with corticosteroid‐induced immunosuppression
por: Mahdavi, Maryam, et al.
Publicado: (2020)

124. Establishment of a Post-Influenza Aspergillosis Model in Corticosteroid-Immunosuppressed Mice
por: Wurster, Sebastian, et al.
Publicado: (2021)

Macrophage migration inhibitory factor urinary excretion revisited – MIF a potent predictor of the immunosuppressive treatment outcomes in patients with proliferative primary glomerulonephritis
por: Zwiech, Rafał
Publicado: (2015)

Potential of immunosuppressive agents in cerebral ischaemia
por: Gupta, Yogendra Kumar, et al.
Publicado: (2011)

Nonimmunologic targets of immunosuppressive agents in podocytes
por: Yoo, Tae-Hyun, et al.
Publicado: (2015)

Hepatitis C-related membranoproliferative glomerulonephritis in the era of direct antiviral agents
por: Abdelhamid, Walid Ahmed Ragab, et al.
Publicado: (2021)

Identification of biomarkers and drug repurposing candidates based on an immune-, inflammation- and membranous glomerulonephritis-associated triplets network for membranous glomerulonephritis
por: Zhang, Chengwei, et al.
Publicado: (2020)

Investigational Drugs for the Treatment of Depression (Part 1): Monoaminergic, Orexinergic, GABA-Ergic, and Anti-Inflammatory Agents
por: Vasiliu, Octavian
Publicado: (2022)

New immunosuppressive agents in pediatric transplantation
por: Nguyen, Christina, et al.
Publicado: (2014)

Prospects for Precision Medicine in Glomerulonephritis Treatment
por: Liu, Yulu Cherry, et al.
Publicado: (2018)

Immunological Mechanisms in Glomerulonephritis
por: Hardwicke, J.
Publicado: (1971)

Cannot write session to /tmp/vufind_sessions/sess_ce2rpb6hvogp9mtnkke7u0f08p